A Look Into Healthcare Sector Value Stocks
A Look Into Healthcare Sector Value Stocks
Understanding Value Stocks
了解價值股
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
傳統上，價值股是根據市場上投資者如何估值該公司的未來增長前景來定義的。低市盈率倍數是表明公司被低估的良好基礎指標，很可能被貼上價值股的標籤。
The following stocks are considered to be notable value stocks in the healthcare sector:
以下股票被認爲是醫療保健領域值得注意的價值股票：
- Nuwellis (NASDAQ:NUWE) - P/E: 0.02
- Exicure (NASDAQ:XCUR) - P/E: 0.33
- Acorda Therapeutics (NASDAQ:ACOR) - P/E: 3.69
- Prenetics Global (NASDAQ:PRE) - P/E: 0.24
- Ocuphire Pharma (NASDAQ:OCUP) - P/E: 2.03
- Nuwellis（納斯達克股票代碼：NUWE）-市盈率：0.02
- Exicure（納斯達克股票代碼：XCUR）-市盈率：0.33
- Acorda Therapeutics（納斯達克股票代碼：ACOR）-市盈率：3.69
- Prenetics Global（納斯達克股票代碼：PRE）-市盈率：0.24
- Ocuphire Pharma（納斯達克股票代碼：OCUP）-市盈率：2.03
Most recently, Nuwellis reported earnings per share at $-1.81, whereas in Q2 earnings per share sat at $-3.65. Exicure has reported Q2 earnings per share at $-0.68, which has increased by 2.86% compared to Q1, which was -0.7. Acorda Therapeutics's earnings per share for Q3 sits at $-7.16, whereas in Q2, they were at -7.55. Prenetics Global looks to be undervalued. It possesses an EPS of $-0.05, which has not changed since last quarter (Q2). Most recently, the company reported a dividend yield of 1.99%, which has decreased by 0.02% from last quarter's yield of 2.01%.
最近，Nuwellis公佈的每股收益爲-1.81美元，而第二季度每股收益爲-3.65美元。Exicure公佈的第二季度每股收益爲-0.68美元，與第一季度的-0.7美元相比增長了2.86％。Acorda Therapeutics第三季度的每股收益爲-7.16美元，而在第二季度，每股收益爲-7.55美元。Prenetics Global似乎被低估了。它的每股收益爲-0.05美元，自上個季度（第二季度）以來一直沒有變化。最近，該公司公佈的股息收益率爲1.99％，較上個季度的2.01％下降了0.02％。
Ocuphire Pharma saw an increase in earnings per share from -0.24 in Q2 to $0.25 now.
Ocuphire Pharma的每股收益從第二季度的-0.24美元增加到現在的0.25美元。
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
意義：價值股可能需要一些時間才能從其被低估的位置中反彈。投資價值股的風險在於，這種出現可能永遠無法實現。
譯文內容由第三人軟體翻譯。